XML 103 R75.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 4 Months Ended 12 Months Ended
Apr. 30, 2024
Feb. 13, 2026
Dec. 31, 2025
Apr. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Nov. 03, 2025
Oct. 31, 2022
Warrants exercised         590,703        
Exercise price of warrants     $ 18.11   $ 18.11        
Proceeds from exercise of warrants         $ 10,698 $ 0 $ 0    
Outstanding warrants     0   0        
Stock repurchased and retired during period, value           $ 0      
Common stock                  
Amount of shares repurchased               $ 125,000 $ 100,000
Stock repurchased and retired during period, shares     227,855 986,928   0 6,173,565    
Shares repurchased average price per share     $ 20.09 $ 15.12     $ 12.39    
Stock repurchased and retired during period, value     $ 4,600 $ 14,900   $ 0 $ 76,500    
Common stock | Subsequent Event                  
Stock repurchased and retired during period, shares   569,443              
Shares repurchased average price per share   $ 19.88              
Stock repurchased and retired during period, value   $ 11,400              
Additional Paid-In Capital                  
Stock repurchased and retired during period, value           $ (393,829)      
Additional Paid-In Capital | GSK                  
Cost of treasury stock $ 393,800